NAS:KROS (USA)   Healthcare » Biotechnology
Keros Therapeutics Inc logo

Keros Therapeutics Inc $ 49.33 -1.59 (-3.12%)

Volume:
114,201
Avg Vol (1m):
158,287
Market Cap $:
1.15 Bil
Enterprise Value $:
894.83 Mil
PE Ratio:
0.00
PB Ratio:
4.62
Warning! GuruFocus has detected 1 Medium warning sign with KROS. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 10Y (-%)

KROS Stock Institutional Ownership and Insider Ownership - Keros Therapeutics Inc

23.3
(Mil)
Shares Outstanding
36.58%
8.52 (Mil)
Institutional Ownership
1.41%
0.33 (Mil)
Insider Ownership
54.98%
12.8094 (Mil)
Float Percentage of TSO

Short Interest History (%)

Due to a license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus’ website, except for certain Australian stocks.

Institutional Ownership History (%)

This the Institutional Ownership History of Keros Therapeutics Inc. Peter Lynch prefers to buy companies with low institutional ownership.
EMBED

Insider ownership (%)

This is the historical insider ownership of Keros Therapeutics Inc. It is usually better to buy companies with large insider ownership. The company insiders' interest are more aligned with external shareholders in this case.

Top Direct Holders

Top Fund Holders